Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced ...
eVTOL stocks are on watch after J.P. Morgan warns hype may be flying too high
J.P. Morgan turned cautious on the eVTOL sector as it attempted to balance the near-term relativeshare price outperformance ...
Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...
Net Lease Office Properties sells five sites for $43M, pays off secured mortgage
Net Lease Office Properties (NYSE:NLOP) sold five office properties in November and December for gross proceeds of $43.3M, ...
manilatimes1h
Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025
Additional clinical results from Phase 1/2 study of MRT-2359 in MYC-driven solid tumors, including biomarker and activity data, anticipated in Q1 2025 MRT-8102, a NEK7-directed MGD targeting diseases ...
Investing55m
Insurance stocks slide on wildfire loss concerns
Allstate, Travelers (NYSE: TRV ), and Chubb were specifically highlighted by the firm as being the most exposed to the California homeowners' market, which is likely to be hit hard by the claims ...